Clinical Trials

Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Behavioral
  • Participants: 24
  • Start Date: April 2021
Healthy Living Partnerships for Veterans With Migraine
Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Behavioral
  • Participants: 200
  • Start Date: March 15, 2021
Mind Body Balance for Pediatric Migraine
Search for trials
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 3
  • Intervention Type: Drug
  • Participants: 300
  • Start Date: September 14, 2020
An Open-Label, 12-Month Study to Evaluate the Safety and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Drug
  • Participants: 72
  • Start Date: July 22, 2020
The Effect of Anti-calcitonin Gene-related Peptide (CGRP) Receptor Antibodies on the Headache Inducing Properties of CGRP and Cilostazol in Migraine Patients
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 40
  • Start Date: November 2019
Acid-Sensing Ion Channel and Migraine Disease Proof of Concept Study on the Efficacy of Amiloride in the Prophylaxis of Migraine Aura
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Other
  • Participants: 600
  • Start Date: February 9, 2018
Sensitivity to Acute Middle Cerebral or Intracranial Carotid Artery Occlusion in MIGrainers - SAMCO-MIG
Clinical Trial
  • Status: Active, not recruiting
  • Phase: N/A
  • Intervention Type: Other
  • Participants: 61
  • Start Date: June 7, 2017
Integrative Migraine Pain Alleviation Through Chiropractic Therapy
Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Other
  • Participants: 20
  • Start Date: January 2017
Understanding the Role of the External Carotid Artery in the Pathophysiology of Migraine Pain
Clinical Trial
  • Status: Active, not recruiting
  • Phase: Early Phase 1
  • Intervention Type: Drug
  • Participants: 16
  • Start Date: June 2015
The Effect of the Selective PDE5 Inhibitor, Sildenafil, on Aura and Migraine Headache Induction.
Showing 1-9 of 9